RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741

J Natl Cancer Inst. 2016 Jan;108(1). doi: 10.1093/jnci/djv333.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Body Mass Index*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Lymph Nodes / pathology*
  • Receptors, Estrogen / analysis*

Substances

  • Receptors, Estrogen